News Chart Celltrion, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 21/01/2026			5-day change	1st Jan Change
204,000.00 ^KRW	-1.45%		-7.69%	+12.71%

01-14	Celltrion Presents Innovative Drug Pipeline and U.S. Manufacturing and R&D Expansion Strategy At the 44Th Annual J.P. Morgan Healthcare Conference	CI
01-06	Abpro, Celltrion Say Solid Cancer Tumor Therapy Investigational New Drug Application Receives US FDA Clearance	MT

8c53eabcf49.6uPELgt2WQnye7EGMDdwknlxH5KZs_xsCv8fzUIH7X0.hJGUTE0SAFCGLtdLB3M_qkEEWPHVxqMaPoxpmCF_gyKpp-lIWREsRaoegQ~b890b91eb26e37522375f9501be2011e